Influenza virus defective recombinants as platforms in the development of bivalent vaccines against flu and swine circovirosis
Project 448
Problem to be solved
-
Absence in the market of a bivalent vaccine to combat these viruses
Proposed innovation
-
Innovative and unprecedented technology in obtaining a vaccine capable of immunizing against the flu and swine circovirosis.
- It is a bivalent vaccine.
- The recombinant Influenza viruses might be employed as vectors to manufacture vaccines against pathogens of medical and veterinary interest.
-
Differential
Stage of development
Laboratory prototype
-
What we want
Partnership
-
Coordinator
Alexandre de Magalhães Vieira Machado / IRR
-
Contact
Gestec/VPPIS – phone: 21 3882 9099/ 3882 9120 or portfolio@fiocruz.br